A prior study has revealed that among the seven detected CTAs, LDHC is the only molecule with a positive expression in all types of pathological tissues of non-small-cell lung cancer (NSCLC), suggesting that LDHC acts as a potential marker for the diagnosis of NSCLC (11). Here, LDHC is linked to non-small cell lung carcinoma.